Table 3.
Primary and Secondary Outcomes from Time-Line Follow-Back
| BI-B | SAR | MSO | Total | |
|---|---|---|---|---|
| Days of use of the primary drug of abuse in the past 30 days at | ||||
| Baseline | 14.8 (11.23) | 16.3 (11.42) | 15.5 (11.34) | |
| 3 month Visit | 9.4 (11.68) | 10.9 (12.09) | 10.5 (11.93) | 10.3 (11.91) |
| 6 Month Visit | 8.2 (11.19) | 9.7 (11.63) | 9.8 (12.14) | 9.2 (11.68) |
| 12 Month Visit | 8.6 (11.17) | 7.9 (11.11) | 8.5 (11.40) | 8.3 (11.22) |
| Days of drug use in the past 30 days at | ||||
| Baseline | 16.4 (11.03) | 18.5 (10.93) | 17.4 (11.03) | |
| 3 Month Visit | 11.9 (12.05) | 13.7 (12.36) | 13.0 (12.11) | 12.9 (12.19) |
| 6 Month Visit | 10.8 (12.05) | 12.5 (12.20) | 12.1 (12.61) | 11.8 (12.31) |
| 12 Month Visit | 10.7 (11.82) | 10.9 (12.08) | 11.0 (12.24) | 10.9 (12.04) |
| Days of heavy drinking in the past 30 days at | ||||
| Baseline | 4.6 (8.38) | 4.3 (8.07) | 4.4 (8.22) | |
| 3 Month Visit | 2.9 (6.72) | 3.3 (7.19) | 3.2 (7.16) | 3.1 (7.03) |
| 6 Month Visit | 3.3 (7.15) | 2.7 (6.33) | 2.6 (6.10) | 2.9 (6.54) |
| 12 Month Visit | 3.3 (7.30) | 2.7 (6.57) | 3.2 (7.26) | 3.1 (7.05) |
Data shown are Mean (S.D.)